65 related articles for article (PubMed ID: 29805758)
21. Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events.
Sinha SS; Cameron J; Brooks JC; Leifer CA
J Immunol; 2016 Aug; 197(4):1343-52. PubMed ID: 27421483
[TBL] [Abstract][Full Text] [Related]
22. On the Dependency of Cellular Protein Levels on mRNA Abundance.
Liu Y; Beyer A; Aebersold R
Cell; 2016 Apr; 165(3):535-50. PubMed ID: 27104977
[TBL] [Abstract][Full Text] [Related]
23. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
[TBL] [Abstract][Full Text] [Related]
26. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
Rossi D; Ciardullo C; Gaidano G
Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
[TBL] [Abstract][Full Text] [Related]
27. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
28. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
[TBL] [Abstract][Full Text] [Related]
29. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors.
Agrawal S; Gupta S
J Clin Immunol; 2011 Feb; 31(1):89-98. PubMed ID: 20821041
[TBL] [Abstract][Full Text] [Related]
30. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).
Baseggio L; Traverse-Glehen A; Callet-Bauchu E; Morel D; Magaud JP; Berger F; Salles G; Felman P
Hematol Oncol; 2011 Mar; 29(1):47-51. PubMed ID: 20677173
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptors: lessons to learn from normal and malignant human B cells.
Chiron D; Bekeredjian-Ding I; Pellat-Deceunynck C; Bataille R; Jego G
Blood; 2008 Sep; 112(6):2205-13. PubMed ID: 18591383
[TBL] [Abstract][Full Text] [Related]
32. Analyzing real-time PCR data by the comparative C(T) method.
Schmittgen TD; Livak KJ
Nat Protoc; 2008; 3(6):1101-8. PubMed ID: 18546601
[TBL] [Abstract][Full Text] [Related]
33. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?
Traverse-Glehen A; Baseggio L; Bauchu EC; Morel D; Gazzo S; Ffrench M; Verney A; Rolland D; Thieblemont C; Magaud JP; Salles G; Coiffier B; Berger F; Felman P
Blood; 2008 Feb; 111(4):2253-60. PubMed ID: 18042795
[TBL] [Abstract][Full Text] [Related]
34. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells.
Grandjenette C; Kennel A; Faure GC; Béné MC; Feugier P
Haematologica; 2007 Sep; 92(9):1279-81. PubMed ID: 17768129
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptors in systemic autoimmune disease.
Marshak-Rothstein A
Nat Rev Immunol; 2006 Nov; 6(11):823-35. PubMed ID: 17063184
[TBL] [Abstract][Full Text] [Related]
36. Control of B-cell responses by Toll-like receptors.
Pasare C; Medzhitov R
Nature; 2005 Nov; 438(7066):364-8. PubMed ID: 16292312
[TBL] [Abstract][Full Text] [Related]
37. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.
Traverse-Glehen A; Davi F; Ben Simon E; Callet-Bauchu E; Felman P; Baseggio L; Gazzo S; Thieblemont C; Charlot C; Coiffier B; Berger F; Salles G
Haematologica; 2005 Apr; 90(4):470-8. PubMed ID: 15820942
[TBL] [Abstract][Full Text] [Related]
38. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
Jahrsdorfer B; Mühlenhoff L; Blackwell SE; Wagner M; Poeck H; Hartmann E; Jox R; Giese T; Emmerich B; Endres S; Weiner GJ; Hartmann G
Clin Cancer Res; 2005 Feb; 11(4):1490-9. PubMed ID: 15746051
[TBL] [Abstract][Full Text] [Related]
39. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.
Bernasconi NL; Onai N; Lanzavecchia A
Blood; 2003 Jun; 101(11):4500-4. PubMed ID: 12560217
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of serological memory by polyclonal activation of human memory B cells.
Bernasconi NL; Traggiai E; Lanzavecchia A
Science; 2002 Dec; 298(5601):2199-202. PubMed ID: 12481138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
